Cholangiocarcinoma  >>  TheraSphere (yttrium 90 microspheres)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraSphere (yttrium 90 microspheres) / Boston Scientific
NCT01434459: Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin

Terminated
1
9
US
Gemcitabine with TheraSphere, TheraSphere_radioembolization, Gemcitabine- Gemzar
Emory University
Pancreatic Neoplasms, Cholangiocarcinoma
01/14
09/14
NCT00858429: Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases

Completed
1
18
US
capecitabine, C14H15FN3O7, prodrug of 5'-deoxy-5-fluorouridine (5'-DFUR), yttrium Y 90 glass microspheres
Northwestern University
Liver Cancer, Metastatic Cancer
03/14
07/14

Download Options